A new class of weight-loss drugs is changing the food industry, but not in the way many expected at first. They could present ...

The demand for bariatric operations dropped sharply last year as use of anti-obesity drugs such as Wegovy surged, study finds ...

Semaglutide outperformed 7 diabetes medications in reducing risk of Alzheimer's disease, according to a study of over 1 ...

Meds like Wegovy are all over the news. But are they right for you, especially if you're older than the average user?By Are ...

Ozempic and other GLP-1 drugs show promise not only in managing obesity and diabetes but also in reducing Alzheimer's risk. A ...

Researchers use real-world data in the United States to evaluate the protective role of semaglutide against Alzherimer’s ...

A new study by researchers at Brigham and Women's Hospital in collaboration with researchers at Harvard T.H. Chan School of ...

GLP-1 drugs like Wegovy (NVO) might help with weight loss, but they aren’t leading to lower health care costs yet, according to a new analysis of U.S. health insurance claims.

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...

The findings spell an uncertain future for hospitals and clinics that derive a significant portion of their revenues from ...

The prevalence of obesity continues to remain high in the US, making the demand for effective treatments even more urgent.

Wegovy and similar weight-loss medications are becoming widely prescribed for teenagers with obesity, but little is known ...